JP2012510803A5 - - Google Patents

Download PDF

Info

Publication number
JP2012510803A5
JP2012510803A5 JP2011539034A JP2011539034A JP2012510803A5 JP 2012510803 A5 JP2012510803 A5 JP 2012510803A5 JP 2011539034 A JP2011539034 A JP 2011539034A JP 2011539034 A JP2011539034 A JP 2011539034A JP 2012510803 A5 JP2012510803 A5 JP 2012510803A5
Authority
JP
Japan
Prior art keywords
isolated
isolated peptide
nucleic acid
protease
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011539034A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012510803A (ja
JP5840498B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/066395 external-priority patent/WO2010063818A2/en
Publication of JP2012510803A publication Critical patent/JP2012510803A/ja
Publication of JP2012510803A5 publication Critical patent/JP2012510803A5/ja
Application granted granted Critical
Publication of JP5840498B2 publication Critical patent/JP5840498B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011539034A 2008-12-05 2009-12-04 プロテアーゼ耐性ポリペプチドを選択するための方法 Active JP5840498B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12013508P 2008-12-05 2008-12-05
US61/120,135 2008-12-05
PCT/EP2009/066395 WO2010063818A2 (en) 2008-12-05 2009-12-04 Methods for selecting protease resistant polypeptides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015147120A Division JP2015231380A (ja) 2008-12-05 2015-07-24 プロテアーゼ耐性ポリペプチドを選択するための方法

Publications (3)

Publication Number Publication Date
JP2012510803A JP2012510803A (ja) 2012-05-17
JP2012510803A5 true JP2012510803A5 (enExample) 2013-01-31
JP5840498B2 JP5840498B2 (ja) 2016-01-06

Family

ID=42169477

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011539034A Active JP5840498B2 (ja) 2008-12-05 2009-12-04 プロテアーゼ耐性ポリペプチドを選択するための方法
JP2015147120A Pending JP2015231380A (ja) 2008-12-05 2015-07-24 プロテアーゼ耐性ポリペプチドを選択するための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015147120A Pending JP2015231380A (ja) 2008-12-05 2015-07-24 プロテアーゼ耐性ポリペプチドを選択するための方法

Country Status (15)

Country Link
US (3) US8685895B2 (enExample)
EP (1) EP2364326B1 (enExample)
JP (2) JP5840498B2 (enExample)
KR (1) KR101740066B1 (enExample)
CN (1) CN102307897B (enExample)
AU (1) AU2009324037B2 (enExample)
BR (1) BRPI0922772B1 (enExample)
CA (1) CA2745448C (enExample)
EA (1) EA026508B1 (enExample)
ES (1) ES2688621T3 (enExample)
IL (1) IL212923A0 (enExample)
MX (1) MX2011005874A (enExample)
SG (1) SG194383A1 (enExample)
WO (1) WO2010063818A2 (enExample)
ZA (1) ZA201103575B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8685895B2 (en) * 2008-12-05 2014-04-01 Carolyn Enever Methods for selecting protease resistant polypeptides
US9012609B2 (en) 2010-08-13 2015-04-21 Glaxosmithkline Intellectual Property Development Limited Anti-serum albumin binding variants
KR20130055663A (ko) * 2010-08-20 2013-05-28 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 개선된 항-혈청 알부민 결합 변이체
EP2866029B1 (en) * 2012-06-22 2017-05-03 Olympus Corporation Method for preparing sample containing pancreatic juice component, and kit for storing biological sample containing pancreatic juice component at room temperature
AU2014290229A1 (en) * 2013-07-15 2016-02-18 North Carolina State University Protease-resistant peptide ligands
JP6422977B2 (ja) * 2013-08-30 2018-11-14 エイプリルバイオ カンパニー リミテッド 抗血清アルブミンfabエフェクター部分融合コンストラクト、およびその製造方法
WO2016191659A1 (en) * 2015-05-28 2016-12-01 Bio-Rad Laboratories, Inc. Affinity ligands and methods relating thereto
TWI726889B (zh) * 2015-06-10 2021-05-11 英商梅迪繆思有限公司 蛋白酶抗性之脂化肽
JP6766253B2 (ja) * 2017-03-28 2020-10-07 森永乳業株式会社 新規ビフィドバクテリウム属細菌
KR20210143766A (ko) * 2019-02-26 2021-11-29 트위스트 바이오사이언스 코포레이션 Glp1 수용체에 대한 변이체 핵산 라이브러리
US11584781B2 (en) * 2019-12-30 2023-02-21 Eligo Bioscience Chimeric receptor binding proteins resistant to proteolytic degradation
KR20210095781A (ko) 2020-01-24 2021-08-03 주식회사 에이프릴바이오 항원결합 단편 및 생리활성 이펙터 모이어티로 구성된 융합 컨스트럭트를 포함하는 다중결합항체 및 이를 포함하는 약학조성물
US12391762B2 (en) 2020-08-26 2025-08-19 Twist Bioscience Corporation Methods and compositions relating to GLP1R variants
US12122817B2 (en) * 2020-09-22 2024-10-22 Serpentide Inc. Long-lasting GLP1 analogue drug for type-2 diabetes

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8725529D0 (en) 1987-10-30 1987-12-02 Delta Biotechnology Ltd Polypeptides
WO1989007142A1 (en) 1988-02-05 1989-08-10 Morrison Sherie L Domain-modified constant region antibodies
EP1997891A1 (en) 1988-09-02 2008-12-03 Dyax Corporation Generation and selection of recombinant varied binding proteins
ATE92107T1 (de) 1989-04-29 1993-08-15 Delta Biotechnology Ltd N-terminale fragmente von menschliches serumalbumin enthaltenden fusionsproteinen.
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5977307A (en) 1989-09-07 1999-11-02 Alkermes, Inc. Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US6172197B1 (en) 1991-07-10 2001-01-09 Medical Research Council Methods for producing members of specific binding pairs
KR100272077B1 (ko) 1990-08-29 2000-11-15 젠팜인터내셔날,인코포레이티드 이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물
DE69132531T2 (de) 1990-12-06 2001-09-13 Affymetrix, Inc. (N.D.Ges.D.Staates Delaware) Verbindungen und ihre Verwendung in einer binären Synthesestrategie
ATE408012T1 (de) 1991-12-02 2008-09-15 Medical Res Council Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken
US5733743A (en) 1992-03-24 1998-03-31 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
WO1994029351A2 (en) 1993-06-16 1994-12-22 Celltech Limited Antibodies
US5702892A (en) 1995-05-09 1997-12-30 The United States Of America As Represented By The Department Of Health And Human Services Phage-display of immunoglobulin heavy chain libraries
CA2229043C (en) 1995-08-18 2016-06-07 Morphosys Gesellschaft Fur Proteinoptimierung Mbh Protein/(poly)peptide libraries
DK1801214T3 (da) 1997-07-07 2011-01-24 Medical Res Council In vitro sorteringsfremgangsmåde
GB9722131D0 (en) 1997-10-20 1997-12-17 Medical Res Council Method
ATE380865T1 (de) 1998-05-13 2007-12-15 Domantis Ltd Phagen-display-selektionssystem für korrekt gefaltete proteine
IL127127A0 (en) 1998-11-18 1999-09-22 Peptor Ltd Small functional units of antibody heavy chain variable regions
JP2003523742A (ja) 2000-02-03 2003-08-12 ドマンティス リミテッド コンビナトリアルタンパク質ドメイン
DK1355942T3 (da) 2000-12-07 2008-11-17 Lilly Co Eli GLP-1-fusionsproteiner
WO2002095076A2 (en) * 2001-05-23 2002-11-28 Kabushiki Kaisha Toyota Chuo Kenkyusho Modified polypeptides having protease-resistance and/or protease-sensitivity
DK1412384T3 (da) 2001-06-28 2008-04-28 Novo Nordisk As Stabil formulering af modificeret GLP-1
WO2003076567A2 (en) 2002-03-05 2003-09-18 Eli Lilly And Company Heterologous g-csf fusion proteins
US20060002935A1 (en) 2002-06-28 2006-01-05 Domantis Limited Tumor Necrosis Factor Receptor 1 antagonists and methods of use therefor
US9321832B2 (en) 2002-06-28 2016-04-26 Domantis Limited Ligand
US7696320B2 (en) 2004-08-24 2010-04-13 Domantis Limited Ligands that have binding specificity for VEGF and/or EGFR and methods of use therefor
EP3299393A1 (en) 2002-11-08 2018-03-28 Ablynx N.V. Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
CA2513213C (en) 2003-01-22 2013-07-30 Human Genome Sciences, Inc. Albumin fusion proteins
TW200526254A (en) 2003-09-19 2005-08-16 Novo Nordisk As Novel GLP-1 derivatives
PT1737962E (pt) 2004-03-24 2010-12-03 Domantis Ltd Sequência líder universal gas1
CA2589800A1 (en) * 2004-12-02 2006-06-08 Domantis Limited Bispecific domain antibodies targeting serum albumin and glp-1 or pyy
MX2009003400A (es) * 2006-10-03 2009-04-28 Cadila Healthcare Ltd Compuestos antidiabeticos.
GB0724331D0 (en) * 2007-12-13 2008-01-23 Domantis Ltd Compositions for pulmonary delivery
EP2259802A1 (en) * 2008-03-31 2010-12-15 Glaxo Group Limited Drug fusions and conjugates
US8685895B2 (en) * 2008-12-05 2014-04-01 Carolyn Enever Methods for selecting protease resistant polypeptides
EA027866B1 (ru) * 2009-02-19 2017-09-29 Глэксо Груп Лимитед Улучшенные связывающие сывороточный альбумин варианты

Similar Documents

Publication Publication Date Title
JP2012510803A5 (enExample)
JP2023179436A5 (enExample)
US20130040877A1 (en) Long-acting y2 receptor agonists
NZ596778A (en) Glucose-regulating polypeptides and methods of making and using same
NZ597685A (en) Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli
JP2010529860A5 (enExample)
JP2014510518A5 (enExample)
JP2013545724A5 (enExample)
JP2007513634A5 (enExample)
JP2016512213A5 (enExample)
JP2016512213A (ja) 肥満の治療のためのペグ化グルカゴン及びglp−1コアゴニスト
US20210221866A1 (en) Protease-resistant lipidated glp-1 analogs
JP2015504052A5 (enExample)
MX2008009493A (es) Peptido novedoso y uso del mismo.
WO2010007144A3 (en) Mutated netrin-4 proteins, fragments thereof and their uses as drugs
WO2023148366A1 (en) Glp-1 and glucagon dual agonist peptides with improved biological stability
CY1111630T1 (el) Παραγωγα κυτοκινων
KR20190017017A (ko) 프로테아제-내성 모노-지질화된 펩타이드
WO2006111946A3 (en) Toll-like receptor 14 (tlr14 ) and use thereof
JP2020511425A5 (enExample)
JP2008517998A5 (enExample)
WO2007064844A3 (en) Anti-viral griffithsin compounds, compositions, and methods of use
DK1913020T3 (da) Immunogene konstrukter
WO2008029138A3 (en) Peptides and methods
DK1960515T3 (da) Inflammationshæmmende peptider